TY  - GEN
AU  - Alhan,Canan
AU  - Westers,Theresia M
AU  - van der Helm,Lieke H
AU  - Eeltink,Corien
AU  - Huls,Gerwin
AU  - Witte,Birgit I
AU  - Buchi,Francesca
AU  - Santini,Valeria
AU  - Ossenkoppele,Gert J
AU  - van de Loosdrecht,Arjan A
TI  - Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes
SN  - 1552-4957
PY  - 2014///1125
KW  - Aged
KW  - Aged, 80 and over
KW  - Antimetabolites, Antineoplastic
KW  - therapeutic use
KW  - Azacitidine
KW  - Biomarkers, Pharmacological
KW  - analysis
KW  - Bone Marrow Cells
KW  - classification
KW  - Female
KW  - Flow Cytometry
KW  - Humans
KW  - Immunophenotyping
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Leukemia, Myelomonocytic, Chronic
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Myeloid Progenitor Cells
KW  - Prognosis
KW  - Research Design
KW  - Retrospective Studies
KW  - Risk Factors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cyto.b.21160
ER  -